메뉴 건너뛰기




Volumn 14, Issue 1, 2014, Pages

Differential expression patterns and clinical significance of estrogen receptor-α and β in papillary thyroid carcinoma

Author keywords

ER ; ER 1; Ki 67; Mutant P53; Papillary thyroid cancer; VEGF

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN RECEPTOR BETA1; KI 67 ANTIGEN; PROTEIN P53; TUMOR MARKER; UNCLASSIFIED DRUG; VASCULOTROPIN; ESTROGEN; ESTROGEN RECEPTOR ALPHA, HUMAN; TP53 PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

EID: 84902077196     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-383     Document Type: Article
Times cited : (82)

References (60)
  • 1
    • 78650197771 scopus 로고    scopus 로고
    • Thyroid cancer gender disparity
    • 10.2217/fon.10.127, 3077966, 21142662
    • Rahbari R, Zhang L, Kebebew E. Thyroid cancer gender disparity. Future Oncol 2010, 6:1771-1779. 10.2217/fon.10.127, 3077966, 21142662.
    • (2010) Future Oncol , vol.6 , pp. 1771-1779
    • Rahbari, R.1    Zhang, L.2    Kebebew, E.3
  • 2
    • 37349131738 scopus 로고    scopus 로고
    • BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications
    • 10.1210/er.2007-0007, 17940185
    • Xing M. BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications. Endocr Rev 2007, 28:742-762. 10.1210/er.2007-0007, 17940185.
    • (2007) Endocr Rev , vol.28 , pp. 742-762
    • Xing, M.1
  • 6
    • 84872684334 scopus 로고    scopus 로고
    • Estrogen receptor signaling as a target for novel breast cancer therapeutics
    • 10.1016/j.bcp.2012.10.018, 23103568
    • Renoir JM, Marsaud V, Lazennec G. Estrogen receptor signaling as a target for novel breast cancer therapeutics. Biochem Pharmacol 2013, 85:449-465. 10.1016/j.bcp.2012.10.018, 23103568.
    • (2013) Biochem Pharmacol , vol.85 , pp. 449-465
    • Renoir, J.M.1    Marsaud, V.2    Lazennec, G.3
  • 7
    • 82355188243 scopus 로고    scopus 로고
    • Minireview: Putting physiology back into estrogens' mechanism of action
    • 10.1210/en.2011-1449, 21952239
    • Koos RD. Minireview: Putting physiology back into estrogens' mechanism of action. Endocrinology 2011, 152:4481-4488. 10.1210/en.2011-1449, 21952239.
    • (2011) Endocrinology , vol.152 , pp. 4481-4488
    • Koos, R.D.1
  • 8
    • 84856121366 scopus 로고    scopus 로고
    • Role of estrogen in thyroid function and growth regulation
    • 3113168, 21687614
    • Santin AP, Furlanetto TW. Role of estrogen in thyroid function and growth regulation. J Thyroid Res 2011, 2011:875125. 3113168, 21687614.
    • (2011) J Thyroid Res , vol.2011 , pp. 875125
    • Santin, A.P.1    Furlanetto, T.W.2
  • 10
    • 84886503852 scopus 로고    scopus 로고
    • Estrogen Induces Metastatic Potential of Papillary Thyroid Cancer Cells through Estrogen Receptor alpha and beta
    • 3810507, 24222765
    • Dong W, Zhang H, Li J, Guan H, He L, Wang Z, Shan Z, Teng W. Estrogen Induces Metastatic Potential of Papillary Thyroid Cancer Cells through Estrogen Receptor alpha and beta. Int J Endocrinol 2013, 2013:941568. 3810507, 24222765.
    • (2013) Int J Endocrinol , vol.2013 , pp. 941568
    • Dong, W.1    Zhang, H.2    Li, J.3    Guan, H.4    He, L.5    Wang, Z.6    Shan, Z.7    Teng, W.8
  • 11
    • 84856249327 scopus 로고    scopus 로고
    • Overexpression of estrogen receptor-alpha in human papillary thyroid carcinomas studied by laser- capture microdissection and molecular biology
    • 10.1111/j.1349-7006.2011.02017.x, 21707866
    • di Vito M, de Santis E, Perrone GA, Mari E, Giordano MC, de Antoni E, Coppola L, Fadda G, Tafani M, Carpi A, Russo MA. Overexpression of estrogen receptor-alpha in human papillary thyroid carcinomas studied by laser- capture microdissection and molecular biology. Cancer Sci 2011, 102:1921-1927. 10.1111/j.1349-7006.2011.02017.x, 21707866.
    • (2011) Cancer Sci , vol.102 , pp. 1921-1927
    • di Vito, M.1    de Santis, E.2    Perrone, G.A.3    Mari, E.4    Giordano, M.C.5    de Antoni, E.6    Coppola, L.7    Fadda, G.8    Tafani, M.9    Carpi, A.10    Russo, M.A.11
  • 12
    • 79954579610 scopus 로고    scopus 로고
    • A high-throughput proteomic approach provides distinct signatures for thyroid cancer behavior
    • 10.1158/1078-0432.CCR-10-2837, 21389096
    • Cheng S, Serra S, Mercado M, Ezzat S, Asa SL. A high-throughput proteomic approach provides distinct signatures for thyroid cancer behavior. Clin Cancer Res 2011, 17:2385-2394. 10.1158/1078-0432.CCR-10-2837, 21389096.
    • (2011) Clin Cancer Res , vol.17 , pp. 2385-2394
    • Cheng, S.1    Serra, S.2    Mercado, M.3    Ezzat, S.4    Asa, S.L.5
  • 13
    • 34748843972 scopus 로고    scopus 로고
    • Immunohistochemical study of oestrogen receptors in 351 human thyroid glands
    • Tavangar SM, Monajemzadeh M, Larijani B, Haghpanah V. Immunohistochemical study of oestrogen receptors in 351 human thyroid glands. Singapore Med J 2007, 48:744-747.
    • (2007) Singapore Med J , vol.48 , pp. 744-747
    • Tavangar, S.M.1    Monajemzadeh, M.2    Larijani, B.3    Haghpanah, V.4
  • 14
    • 77149162368 scopus 로고    scopus 로고
    • Controversies in thyroid pathology: thyroid capsule invasion and extrathyroidal extension
    • 10.1245/s10434-009-0832-7, 19949881
    • Mete O, Rotstein L, Asa SL. Controversies in thyroid pathology: thyroid capsule invasion and extrathyroidal extension. Ann Surg Oncol 2010, 17:386-391. 10.1245/s10434-009-0832-7, 19949881.
    • (2010) Ann Surg Oncol , vol.17 , pp. 386-391
    • Mete, O.1    Rotstein, L.2    Asa, S.L.3
  • 15
    • 79951580063 scopus 로고    scopus 로고
    • High endogenous avidin binding activity: an inexpensive and readily available marker for the differential diagnosis of kidney neoplasms
    • 2480577, 18787626
    • Kanehira K, Hu J, Pier T, Sebree L, Huang W. High endogenous avidin binding activity: an inexpensive and readily available marker for the differential diagnosis of kidney neoplasms. Int J Clin Exp Pathol 2008, 1:435-439. 2480577, 18787626.
    • (2008) Int J Clin Exp Pathol , vol.1 , pp. 435-439
    • Kanehira, K.1    Hu, J.2    Pier, T.3    Sebree, L.4    Huang, W.5
  • 16
    • 84902107200 scopus 로고    scopus 로고
    • Endogenous avidin-binding activity in papillary thyroid carcinoma and nodular goiter tissues and its clinical significance
    • Lian Y, Li J, Huang Y, Dong W, Shan Z, Teng W, Zhang H. Endogenous avidin-binding activity in papillary thyroid carcinoma and nodular goiter tissues and its clinical significance. Endocrine 2012, 32:466-468.
    • (2012) Endocrine , vol.32 , pp. 466-468
    • Lian, Y.1    Li, J.2    Huang, Y.3    Dong, W.4    Shan, Z.5    Teng, W.6    Zhang, H.7
  • 17
    • 0031915998 scopus 로고    scopus 로고
    • Prognostic and predictive factors in breast cancer by immunohistochemical analysis
    • Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1998, 11:155-168.
    • (1998) Mod Pathol , vol.11 , pp. 155-168
    • Allred, D.C.1    Harvey, J.M.2    Berardo, M.3    Clark, G.M.4
  • 18
    • 84874512355 scopus 로고    scopus 로고
    • The Ki-67/MIB-1 index level and recurrence of papillary thyroid carcinoma
    • 10.1016/j.mehy.2012.12.015, 23313072
    • Ranjbari N, Rahim F. The Ki-67/MIB-1 index level and recurrence of papillary thyroid carcinoma. Med Hypotheses 2013, 80:311-314. 10.1016/j.mehy.2012.12.015, 23313072.
    • (2013) Med Hypotheses , vol.80 , pp. 311-314
    • Ranjbari, N.1    Rahim, F.2
  • 19
    • 0035342542 scopus 로고    scopus 로고
    • P53 Mutations are present in colorectal cancer with cytoplasmic p53 accumulation
    • 10.1002/ijc.1189, 11291068
    • Jansson A, Gentile M, Sun XF. p53 Mutations are present in colorectal cancer with cytoplasmic p53 accumulation. Int J Cancer 2001, 92:338-341. 10.1002/ijc.1189, 11291068.
    • (2001) Int J Cancer , vol.92 , pp. 338-341
    • Jansson, A.1    Gentile, M.2    Sun, X.F.3
  • 21
    • 33644758292 scopus 로고    scopus 로고
    • Control of cell migration: a tumour suppressor function for p53?
    • 10.1042/BC20050058, 16480340
    • Roger L, Gadea G, Roux P. Control of cell migration: a tumour suppressor function for p53?. Biol Cell 2006, 98:141-152. 10.1042/BC20050058, 16480340.
    • (2006) Biol Cell , vol.98 , pp. 141-152
    • Roger, L.1    Gadea, G.2    Roux, P.3
  • 22
    • 84866290088 scopus 로고    scopus 로고
    • Prognostic value of oncoprotein expressions in thyroid papillary carcinoma
    • 10.1007/s12032-011-9969-x, 21547408
    • Balta AZ, Filiz AI, Kurt Y, Sucullu I, Yucel E, Akin ML. Prognostic value of oncoprotein expressions in thyroid papillary carcinoma. Med Oncol 2012, 29:734-741. 10.1007/s12032-011-9969-x, 21547408.
    • (2012) Med Oncol , vol.29 , pp. 734-741
    • Balta, A.Z.1    Filiz, A.I.2    Kurt, Y.3    Sucullu, I.4    Yucel, E.5    Akin, M.L.6
  • 24
    • 84884413106 scopus 로고    scopus 로고
    • Co-regulatory potential of vascular endothelial growth factor-A and vascular endothelial growth factor-C in thyroid carcinoma
    • 10.1016/j.humpath.2013.04.014, 23845470
    • Salajegheh A, Pakneshan S, Rahman A, Dolan-Evans E, Zhang S, Kwong E, Gopalan V, Lo CY, Smith RA, Lam AK. Co-regulatory potential of vascular endothelial growth factor-A and vascular endothelial growth factor-C in thyroid carcinoma. Hum Pathol 2013, 44:2204-2212. 10.1016/j.humpath.2013.04.014, 23845470.
    • (2013) Hum Pathol , vol.44 , pp. 2204-2212
    • Salajegheh, A.1    Pakneshan, S.2    Rahman, A.3    Dolan-Evans, E.4    Zhang, S.5    Kwong, E.6    Gopalan, V.7    Lo, C.Y.8    Smith, R.A.9    Lam, A.K.10
  • 25
    • 23744447497 scopus 로고    scopus 로고
    • Integration of the extranuclear and nuclear actions of estrogen
    • 10.1210/me.2004-0390, 1249516, 15705661
    • Levin ER. Integration of the extranuclear and nuclear actions of estrogen. Mol Endocrinol 2005, 19:1951-1959. 10.1210/me.2004-0390, 1249516, 15705661.
    • (2005) Mol Endocrinol , vol.19 , pp. 1951-1959
    • Levin, E.R.1
  • 26
    • 6444230377 scopus 로고    scopus 로고
    • Expression of estrogen receptor-beta isoforms in Barrett's metaplasia, dysplasia and esophageal adenocarcinoma
    • Liu L, Chirala M, Younes M. Expression of estrogen receptor-beta isoforms in Barrett's metaplasia, dysplasia and esophageal adenocarcinoma. Anticancer Res 2004, 24:2919-2924.
    • (2004) Anticancer Res , vol.24 , pp. 2919-2924
    • Liu, L.1    Chirala, M.2    Younes, M.3
  • 27
    • 79958746690 scopus 로고    scopus 로고
    • Nuclear and cytoplasmic expressions of ERbeta1 and ERbeta2 are predictive of response to therapy and alters prognosis in familial breast cancers
    • 10.1007/s10549-010-0941-9, 20490651
    • Yan M, Rayoo M, Takano EA, Fox SB. Nuclear and cytoplasmic expressions of ERbeta1 and ERbeta2 are predictive of response to therapy and alters prognosis in familial breast cancers. Breast Cancer Res Treat 2011, 126:395-405. 10.1007/s10549-010-0941-9, 20490651.
    • (2011) Breast Cancer Res Treat , vol.126 , pp. 395-405
    • Yan, M.1    Rayoo, M.2    Takano, E.A.3    Fox, S.B.4
  • 28
    • 78649335764 scopus 로고    scopus 로고
    • Selectively targeting estrogen receptors for cancer treatment
    • 10.1016/j.addr.2010.08.001, 2991615, 20708050
    • Shanle EK, Xu W. Selectively targeting estrogen receptors for cancer treatment. Adv Drug Deliv Rev 2010, 62:1265-1276. 10.1016/j.addr.2010.08.001, 2991615, 20708050.
    • (2010) Adv Drug Deliv Rev , vol.62 , pp. 1265-1276
    • Shanle, E.K.1    Xu, W.2
  • 29
    • 84858073978 scopus 로고    scopus 로고
    • Investigation of immunohistochemical ERalpha, ERbeta and ERbetacx expressions in normal and neoplastic breast tissues
    • 10.1016/j.prp.2011.12.015, 22336175
    • Bozkurt KK, Kapucuoglu N. Investigation of immunohistochemical ERalpha, ERbeta and ERbetacx expressions in normal and neoplastic breast tissues. Pathol Res Pract 2012, 208:133-139. 10.1016/j.prp.2011.12.015, 22336175.
    • (2012) Pathol Res Pract , vol.208 , pp. 133-139
    • Bozkurt, K.K.1    Kapucuoglu, N.2
  • 30
    • 70449434786 scopus 로고    scopus 로고
    • Expression of oestrogen receptors, ERalpha, ERbeta, and ERbeta variants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ERalpha
    • 10.1186/1471-2407-9-330, 2755482, 19758455
    • Collins F, MacPherson S, Brown P, Bombail V, Williams AR, Anderson RA, Jabbour HN, Saunders PT. Expression of oestrogen receptors, ERalpha, ERbeta, and ERbeta variants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ERalpha. BMC Cancer 2009, 9:330. 10.1186/1471-2407-9-330, 2755482, 19758455.
    • (2009) BMC Cancer , vol.9 , pp. 330
    • Collins, F.1    MacPherson, S.2    Brown, P.3    Bombail, V.4    Williams, A.R.5    Anderson, R.A.6    Jabbour, H.N.7    Saunders, P.T.8
  • 31
    • 7444228088 scopus 로고    scopus 로고
    • Advanced maternal age-how old is too old?
    • 10.1056/NEJMp048087, 15525717
    • Heffner LJ. Advanced maternal age-how old is too old?. N Engl J Med 2004, 351:1927-1929. 10.1056/NEJMp048087, 15525717.
    • (2004) N Engl J Med , vol.351 , pp. 1927-1929
    • Heffner, L.J.1
  • 32
    • 0028220251 scopus 로고
    • Hormonal treatment of postmenopausal women
    • 10.1056/NEJM199404143301508, 8127335
    • Belchetz PE. Hormonal treatment of postmenopausal women. N Engl J Med 1994, 330:1062-1071. 10.1056/NEJM199404143301508, 8127335.
    • (1994) N Engl J Med , vol.330 , pp. 1062-1071
    • Belchetz, P.E.1
  • 33
    • 77954818058 scopus 로고    scopus 로고
    • The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM
    • 10.1245/s10434-010-0985-4, 20180029
    • Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010, 17:1471-1474. 10.1245/s10434-010-0985-4, 20180029.
    • (2010) Ann Surg Oncol , vol.17 , pp. 1471-1474
    • Edge, S.B.1    Compton, C.C.2
  • 34
    • 0027293378 scopus 로고
    • Immunohistochemical study of estrogen receptors and the responsiveness to estrogen in papillary thyroid carcinoma
    • 10.1002/1097-0142(19930815)72:4<1364::AID-CNCR2820720435>3.0.CO;2-2, 8339226
    • Inoue H, Oshimo K, Miki H, Kawano M, Monden Y. Immunohistochemical study of estrogen receptors and the responsiveness to estrogen in papillary thyroid carcinoma. Cancer 1993, 72:1364-1368. 10.1002/1097-0142(19930815)72:4<1364::AID-CNCR2820720435>3.0.CO;2-2, 8339226.
    • (1993) Cancer , vol.72 , pp. 1364-1368
    • Inoue, H.1    Oshimo, K.2    Miki, H.3    Kawano, M.4    Monden, Y.5
  • 36
    • 40449099300 scopus 로고    scopus 로고
    • The contributions of oestrogen receptor isoforms to the development of papillary and anaplastic thyroid carcinomas
    • Zeng Q, Chen G, Vlantis A, Tse G, van Hasselt C. The contributions of oestrogen receptor isoforms to the development of papillary and anaplastic thyroid carcinomas. J Pathol 2008, 214:425-433.
    • (2008) J Pathol , vol.214 , pp. 425-433
    • Zeng, Q.1    Chen, G.2    Vlantis, A.3    Tse, G.4    van Hasselt, C.5
  • 37
    • 84875726201 scopus 로고    scopus 로고
    • Loss of estrogen receptor Beta expression in follicular thyroid carcinoma predicts poor outcome
    • 10.1089/thy.2012.0363, 23106428
    • Heikkila A, Hagstrom J, Maenpaa H, Louhimo J, Siironen P, Heiskanen I, Haglund C, Arola J. Loss of estrogen receptor Beta expression in follicular thyroid carcinoma predicts poor outcome. Thyroid 2013, 23:456-465. 10.1089/thy.2012.0363, 23106428.
    • (2013) Thyroid , vol.23 , pp. 456-465
    • Heikkila, A.1    Hagstrom, J.2    Maenpaa, H.3    Louhimo, J.4    Siironen, P.5    Heiskanen, I.6    Haglund, C.7    Arola, J.8
  • 38
  • 39
    • 84866113270 scopus 로고    scopus 로고
    • Differential expression patterns of estrogen receptor (ER)-beta splice variants between papillary thyroid cancer and nodular thyroid goiter
    • 3560661, 22936184
    • Dong W, Li J, Huang Y, Zhang H, Shan Z, Teng W. Differential expression patterns of estrogen receptor (ER)-beta splice variants between papillary thyroid cancer and nodular thyroid goiter. Med Sci Monit 2012, 18:BR351-BR355. 3560661, 22936184.
    • (2012) Med Sci Monit , vol.18
    • Dong, W.1    Li, J.2    Huang, Y.3    Zhang, H.4    Shan, Z.5    Teng, W.6
  • 40
    • 79952701096 scopus 로고    scopus 로고
    • Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma
    • 10.1016/j.anndiagpath.2010.11.005, 21315633
    • Tan A, Etit D, Bayol U, Altinel D, Tan S. Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma. Ann Diagn Pathol 2011, 15:108-116. 10.1016/j.anndiagpath.2010.11.005, 21315633.
    • (2011) Ann Diagn Pathol , vol.15 , pp. 108-116
    • Tan, A.1    Etit, D.2    Bayol, U.3    Altinel, D.4    Tan, S.5
  • 41
    • 0032587780 scopus 로고    scopus 로고
    • Downregulation of p27KIP1 and Ki67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories
    • 10.1097/00000478-199906000-00007, 10366150
    • Tallini G, Garcia-Rostan G, Herrero A, Zelterman D, Viale G, Bosari S, Carcangiu ML. Downregulation of p27KIP1 and Ki67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories. Am J Surg Pathol 1999, 23:678-685. 10.1097/00000478-199906000-00007, 10366150.
    • (1999) Am J Surg Pathol , vol.23 , pp. 678-685
    • Tallini, G.1    Garcia-Rostan, G.2    Herrero, A.3    Zelterman, D.4    Viale, G.5    Bosari, S.6    Carcangiu, M.L.7
  • 42
    • 73949133701 scopus 로고    scopus 로고
    • Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases
    • 10.1097/PAS.0b013e3181c46677, 19956062
    • Asioli S, Erickson LA, Sebo TJ, Zhang J, Jin L, Thompson GB, Lloyd RV. Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases. Am J Surg Pathol 2010, 34:44-52. 10.1097/PAS.0b013e3181c46677, 19956062.
    • (2010) Am J Surg Pathol , vol.34 , pp. 44-52
    • Asioli, S.1    Erickson, L.A.2    Sebo, T.J.3    Zhang, J.4    Jin, L.5    Thompson, G.B.6    Lloyd, R.V.7
  • 43
    • 84859466508 scopus 로고    scopus 로고
    • Prognostic factors of papillary and follicular carcinomas in Japan based on data of kuma hospital
    • 3184434, 21977332
    • Ito Y, Miyauchi A. Prognostic factors of papillary and follicular carcinomas in Japan based on data of kuma hospital. J Thyroid Res 2012, 2012:973497. 3184434, 21977332.
    • (2012) J Thyroid Res , vol.2012 , pp. 973497
    • Ito, Y.1    Miyauchi, A.2
  • 44
    • 84866762466 scopus 로고    scopus 로고
    • Developments in Ki67 and other biomarkers for treatment decision making in breast cancer
    • 10.1093/annonc/mds307, 22987966
    • Sheri A, Dowsett M. Developments in Ki67 and other biomarkers for treatment decision making in breast cancer. Ann Oncol 2012, 23(Suppl 10):x219-x227. 10.1093/annonc/mds307, 22987966.
    • (2012) Ann Oncol , vol.23 , Issue.SUPPL. 10
    • Sheri, A.1    Dowsett, M.2
  • 45
    • 84862012471 scopus 로고    scopus 로고
    • Expression of the proliferation marker Ki-67 associates with tumour staging and clinical outcome in differentiated thyroid carcinomas
    • 10.1111/j.1365-2265.2012.04343.x, 22248072
    • Mussig K, Wehrmann T, Dittmann H, Wehrmann M, Ueberberg B, Schulz S, Bares R, Petersenn S. Expression of the proliferation marker Ki-67 associates with tumour staging and clinical outcome in differentiated thyroid carcinomas. Clin Endocrinol (Oxf) 2012, 77:139-145. 10.1111/j.1365-2265.2012.04343.x, 22248072.
    • (2012) Clin Endocrinol (Oxf) , vol.77 , pp. 139-145
    • Mussig, K.1    Wehrmann, T.2    Dittmann, H.3    Wehrmann, M.4    Ueberberg, B.5    Schulz, S.6    Bares, R.7    Petersenn, S.8
  • 46
    • 36249026963 scopus 로고    scopus 로고
    • Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen receptor-ERK pathway
    • 10.1111/j.1365-2184.2007.00471.x, 18021179
    • Zeng Q, Chen GG, Vlantis AC, van Hasselt CA. Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen receptor-ERK pathway. Cell Prolif 2007, 40:921-935. 10.1111/j.1365-2184.2007.00471.x, 18021179.
    • (2007) Cell Prolif , vol.40 , pp. 921-935
    • Zeng, Q.1    Chen, G.G.2    Vlantis, A.C.3    van Hasselt, C.A.4
  • 47
    • 48849088148 scopus 로고    scopus 로고
    • Regulation of cell growth by estrogen signaling and potential targets in thyroid cancer
    • 10.2174/156800908785133150, 18690843
    • Chen GG, Vlantis AC, Zeng Q, van Hasselt CA. Regulation of cell growth by estrogen signaling and potential targets in thyroid cancer. Curr Cancer Drug Targets 2008, 8:367-377. 10.2174/156800908785133150, 18690843.
    • (2008) Curr Cancer Drug Targets , vol.8 , pp. 367-377
    • Chen, G.G.1    Vlantis, A.C.2    Zeng, Q.3    van Hasselt, C.A.4
  • 48
    • 78650308849 scopus 로고    scopus 로고
    • Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies
    • 10.1038/cgt.2010.63, 20966976
    • Goldstein I, Marcel V, Olivier M, Oren M, Rotter V, Hainaut P. Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies. Cancer Gene Ther 2011, 18:2-11. 10.1038/cgt.2010.63, 20966976.
    • (2011) Cancer Gene Ther , vol.18 , pp. 2-11
    • Goldstein, I.1    Marcel, V.2    Olivier, M.3    Oren, M.4    Rotter, V.5    Hainaut, P.6
  • 49
    • 77956924338 scopus 로고    scopus 로고
    • Immunohistochemical characteristics of diffuse sclerosing variant of papillary carcinoma: comparison with conventional papillary carcinoma
    • 10.1111/j.1600-0463.2010.02653.x, 20854468
    • Koo JS, Shin E, Hong SW. Immunohistochemical characteristics of diffuse sclerosing variant of papillary carcinoma: comparison with conventional papillary carcinoma. APMIS 2010, 118:744-752. 10.1111/j.1600-0463.2010.02653.x, 20854468.
    • (2010) APMIS , vol.118 , pp. 744-752
    • Koo, J.S.1    Shin, E.2    Hong, S.W.3
  • 50
    • 56349145548 scopus 로고    scopus 로고
    • Clinical significance of p53 protein expression in papillary thyroid carcinoma
    • 10.1007/s00268-008-9756-9, 18836853
    • Morita N, Ikeda Y, Takami H. Clinical significance of p53 protein expression in papillary thyroid carcinoma. World J Surg 2008, 32:2617-2622. 10.1007/s00268-008-9756-9, 18836853.
    • (2008) World J Surg , vol.32 , pp. 2617-2622
    • Morita, N.1    Ikeda, Y.2    Takami, H.3
  • 52
    • 0034921646 scopus 로고    scopus 로고
    • P53 mutations in thyroid carcinoma: tidings from an old foe
    • Farid NR. P53 mutations in thyroid carcinoma: tidings from an old foe. J Endocrinol Invest 2001, 24:536-545.
    • (2001) J Endocrinol Invest , vol.24 , pp. 536-545
    • Farid, N.R.1
  • 53
    • 0842269247 scopus 로고    scopus 로고
    • The importance of p53 location: nuclear or cytoplasmic zip code?
    • 10.1016/j.drup.2003.10.004, 14744495
    • O'Brate A, Giannakakou P. The importance of p53 location: nuclear or cytoplasmic zip code?. Drug Resist Updat 2003, 6:313-322. 10.1016/j.drup.2003.10.004, 14744495.
    • (2003) Drug Resist Updat , vol.6 , pp. 313-322
    • O'Brate, A.1    Giannakakou, P.2
  • 54
    • 77953605663 scopus 로고    scopus 로고
    • Immunohistochemical evaluation of inflammatory and proliferative markers in adjacent normal thyroid tissue in patients undergoing total thyroidectomy: results of a preliminary study
    • 10.1186/1756-9966-29-77, 2898684, 20565793
    • Ardito G, Revelli L, Boninsegna A, Sgambato A, Moschella F, Marzola MC, Giustozzi E, Avenia N, Castelli M, Rubello D. Immunohistochemical evaluation of inflammatory and proliferative markers in adjacent normal thyroid tissue in patients undergoing total thyroidectomy: results of a preliminary study. J Exp Clin Cancer Res 2010, 29:77. 10.1186/1756-9966-29-77, 2898684, 20565793.
    • (2010) J Exp Clin Cancer Res , vol.29 , pp. 77
    • Ardito, G.1    Revelli, L.2    Boninsegna, A.3    Sgambato, A.4    Moschella, F.5    Marzola, M.C.6    Giustozzi, E.7    Avenia, N.8    Castelli, M.9    Rubello, D.10
  • 55
    • 76549137189 scopus 로고    scopus 로고
    • Estrogen receptor acting in cis enhances WT and mutant p53 transactivation at canonical and noncanonical p53 target sequences
    • 10.1073/pnas.0909129107, 2824383, 20080630
    • Menendez D, Inga A, Resnick MA. Estrogen receptor acting in cis enhances WT and mutant p53 transactivation at canonical and noncanonical p53 target sequences. Proc Natl Acad Sci U S A 2010, 107:1500-1505. 10.1073/pnas.0909129107, 2824383, 20080630.
    • (2010) Proc Natl Acad Sci U S A , vol.107 , pp. 1500-1505
    • Menendez, D.1    Inga, A.2    Resnick, M.A.3
  • 56
    • 79953745315 scopus 로고    scopus 로고
    • Correlation of E-cadherin, VEGF, COX-2 expression to prognostic parameters in papillary thyroid carcinoma
    • 10.1016/j.yexmp.2011.01.008, 21335003
    • Erdem H, Gundogdu C, Sipal S. Correlation of E-cadherin, VEGF, COX-2 expression to prognostic parameters in papillary thyroid carcinoma. Exp Mol Pathol 2011, 90:312-317. 10.1016/j.yexmp.2011.01.008, 21335003.
    • (2011) Exp Mol Pathol , vol.90 , pp. 312-317
    • Erdem, H.1    Gundogdu, C.2    Sipal, S.3
  • 57
    • 52049102013 scopus 로고    scopus 로고
    • Relationship between protein expression of VEGF-C, MMP-2 and lymph node metastasis in papillary thyroid cancer
    • 10.1177/147323000803600411, 18652765
    • Tian X, Cong M, Zhou W, Zhu J, Liu Q. Relationship between protein expression of VEGF-C, MMP-2 and lymph node metastasis in papillary thyroid cancer. J Int Med Res 2008, 36:699-703. 10.1177/147323000803600411, 18652765.
    • (2008) J Int Med Res , vol.36 , pp. 699-703
    • Tian, X.1    Cong, M.2    Zhou, W.3    Zhu, J.4    Liu, Q.5
  • 58
    • 84874516309 scopus 로고    scopus 로고
    • Activation of estrogen receptor beta reduces blood-brain barrier breakdown following ischemic injury
    • Shin JA, Yang SJ, Jeong SI, Park HJ, Choi YH, Park EM. Activation of estrogen receptor beta reduces blood-brain barrier breakdown following ischemic injury. Neuroscience 2013, 235:165-173.
    • (2013) Neuroscience , vol.235 , pp. 165-173
    • Shin, J.A.1    Yang, S.J.2    Jeong, S.I.3    Park, H.J.4    Choi, Y.H.5    Park, E.M.6
  • 59
    • 84860389636 scopus 로고    scopus 로고
    • Estrogen receptor beta inhibits transcriptional activity of hypoxia inducible factor-1 through the downregulation of arylhydrocarbon receptor nuclear translocator
    • 10.1186/bcr2854, 3219195, 21435239
    • Lim W, Park Y, Cho J, Park C, Park J, Park YK, Park H, Lee Y. Estrogen receptor beta inhibits transcriptional activity of hypoxia inducible factor-1 through the downregulation of arylhydrocarbon receptor nuclear translocator. Breast Cancer Res 2011, 13:R32. 10.1186/bcr2854, 3219195, 21435239.
    • (2011) Breast Cancer Res , vol.13
    • Lim, W.1    Park, Y.2    Cho, J.3    Park, C.4    Park, J.5    Park, Y.K.6    Park, H.7    Lee, Y.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.